• Form Bio’s Oct. 23, 2026, correction removed director and auditor appointments from its extraordinary shareholder meeting agenda, leaving only articles-of-incorporation amendments.
• The meeting remains scheduled for Nov. 10, 2026, at 10 a.m.; the Oct. 19, 2026, voting record date is unchanged.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Form Bio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261023900439), on October 23, 2026, and is solely responsible for the information contained therein.